%0 Journal Article
%T Management of bicuspid aortic valve disease in the transcatheter aortic valve implantation era.
%A Jahangiri M
%A Prendergast B
%J Heart
%V 0
%N 0
%D 2024 Aug 7
%M 39117383
%F 7.365
%R 10.1136/heartjnl-2024-324054
%X In an era of rapidly expanding use of transcatheter aortic valve implantation (TAVI), the management of patients with bicuspid aortic valve (BAV) disease is far less well established than in those with trileaflet anatomy. Results of isolated surgical aortic valve replacement are excellent in suitable patients, and surgery also allows treatment of concomitant pathology of the aortic root and ascending aorta that is frequently encountered in this cohort. Conversely, TAVI provides an excellent alternative in older patients who may be unsuitable for surgery, although outcomes in BAV disease have only been reported in relatively small non-randomised series. Here, we discuss the pertinent literature on this topic and outline contemporary interventional treatment options in this challenging setting.